Beijing Wantai Shares Outstanding vs. Total Debt

603392 Stock   76.62  0.60  0.79%   
Considering the key profitability indicators obtained from Beijing Wantai's historical financial statements, Beijing Wantai Biological may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Beijing Wantai's ability to earn profits and add value for shareholders.
For Beijing Wantai profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Beijing Wantai to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Beijing Wantai Biological utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Beijing Wantai's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Beijing Wantai Biological over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Beijing Wantai's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beijing Wantai is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beijing Wantai's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Beijing Wantai Biological Total Debt vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Beijing Wantai's current stock value. Our valuation model uses many indicators to compare Beijing Wantai value to that of its competitors to determine the firm's financial worth.
Beijing Wantai Biological is number one stock in shares outstanding category among its peers. It also is the top company in total debt category among its peers making up about  0.06  of Total Debt per Shares Outstanding. The ratio of Shares Outstanding to Total Debt for Beijing Wantai Biological is roughly  15.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Wantai by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Wantai's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Beijing Total Debt vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Beijing Wantai

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
1.27 B
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Beijing Wantai

Total Debt

 = 

Bonds

+

Notes

 = 
81.14 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Beijing Total Debt vs Competition

Beijing Wantai Biological is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 6.31 Billion. Beijing Wantai claims roughly 81.14 Million in total debt contributing just under 2% to equities under Health Care industry.
Total debt  Workforce  Capitalization  Valuation  Revenue

Beijing Wantai Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Beijing Wantai, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Beijing Wantai will eventually generate negative long term returns. The profitability progress is the general direction of Beijing Wantai's change in net profit over the period of time. It can combine multiple indicators of Beijing Wantai, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income80 M84 M
Interest Income88 M83.6 M
Operating Income1.6 B1.5 B
Net Income From Continuing Ops1.2 B1.3 B
Income Before Tax1.4 B1.5 B
Net Income Applicable To Common Shares5.4 B5.7 B
Net Income1.2 B1.3 B
Income Tax Expense827.3 M868.7 M
Change To Netincome203.4 M213.6 M

Beijing Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Beijing Wantai. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Beijing Wantai position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Beijing Wantai's important profitability drivers and their relationship over time.

Use Beijing Wantai in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Beijing Wantai position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beijing Wantai will appreciate offsetting losses from the drop in the long position's value.

Beijing Wantai Pair Trading

Beijing Wantai Biological Pair Trading Analysis

The ability to find closely correlated positions to Beijing Wantai could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Beijing Wantai when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beijing Wantai - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beijing Wantai Biological to buy it.
The correlation of Beijing Wantai is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beijing Wantai moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beijing Wantai Biological moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beijing Wantai can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Beijing Wantai position

In addition to having Beijing Wantai in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs
Volatility ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Beijing Stock

To fully project Beijing Wantai's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Beijing Wantai Biological at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Beijing Wantai's income statement, its balance sheet, and the statement of cash flows.
Potential Beijing Wantai investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Beijing Wantai investors may work on each financial statement separately, they are all related. The changes in Beijing Wantai's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Beijing Wantai's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.